Zydus Lifesciences Ltd. recalled Chlorpromazine Hydrochloride Tablets on September 3, 2025. The recall affects 10 mg tablets sold nationwide due to contamination with N-Nitroso Desmethyl Chlorpromazine. Consumers should stop using the product immediately and consult healthcare providers.
CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit
Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 10 mg, sold in 100-count bottles. The affected lot numbers include Z403011 and Z407335 with expiration dates of April 30, 2026, and November 30, 2026, respectively.
The recall stems from CGMP deviations revealing N-Nitroso Desmethyl Chlorpromazine levels exceeding acceptable limits. This contamination poses serious health risks.
No specific incidents or injuries have been reported related to this recall. However, the contamination could lead to severe health implications.
Consumers and healthcare providers should stop using the product immediately. Contact Zydus Pharmaceuticals (USA) Inc for further guidance.
For assistance, contact Zydus Pharmaceuticals at [Contact Number Missing]. More details can be found at the FDA's website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.